University of Virginia Brain Institute and School of Medicine researchers have received an initial $9.3 million award from the National Institutes of Health for a $30 million clinical trial to ...
The funding agency aims to cap “indirect costs” in biomedical research grants. But this behind-the-scenes work is crucial to making research happen.
After weeks of disruption to scientific federal grants, the National Institutes of Health has fallen behind in funding ...
Private investment in pharmaceutical research can't replace the NIH. Both public investment and the private sector are needed ...
This is seismic,” said Dr. Colin Duckett, vice dean for basic and preclinical science at the Duke University School of ...